Center for Evaluation and Survey Research, HealthPartners Institute, Minneapolis, MN, USA.
University of Minnesota, Minneapolis, MN, USA.
J Natl Cancer Inst Monogr. 2024 Aug 15;2024(66):218-223. doi: 10.1093/jncimonographs/lgad029.
Cannabis use among individuals with cancer is best understood using survey self-report. As cannabis remains federally illegal, surveys could be subject to nonresponse and measurement issues impacting data quality. We surveyed individuals using medical cannabis for a cancer-related condition in the Minnesota Medical Cannabis Program (MCP). Although survey responders are older, there are no differences by race and ethnicity, gender, or receipt of reduced cannabis registry enrollment fee. Responders made a more recent purchase and more recently completed an independent symptom assessment for the registry than nonresponders, suggesting some opportunity for nonresponse error. Among responders, self-report and MCP administrative data with respect to age, race, gender, registry certification, and cannabis purchase history were similar. Responders were less likely to report receipt of Medicaid than would be expected based on registry low-income enrollment eligibility. Although attention should be paid to potential for nonresponse error, surveys are a reliable tool to ascertain cannabis behavior patterns in this population.
在癌症患者中使用大麻的情况最好通过调查的自我报告来理解。由于大麻在联邦层面上仍然是非法的，因此调查可能会受到影响数据质量的无应答和测量问题的影响。我们调查了在明尼苏达州医用大麻项目（MCP）中因癌症相关病症而使用医用大麻的个人。尽管调查应答者年龄较大，但在种族和民族、性别或是否获得减少大麻登记注册费方面没有差异。应答者比未应答者最近进行了一次购买，并且最近完成了登记注册的独立症状评估，这表明存在一些无应答错误的可能性。在应答者中，关于年龄、种族、性别、登记注册认证和大麻购买史的自我报告和 MCP 行政数据相似。与根据登记注册的低收入登记注册资格所预期的相比，应答者报告获得医疗补助的可能性较小。尽管应该注意潜在的无应答错误，但调查是确定该人群中大麻行为模式的可靠工具。
